Archer Investment Corp Guardant Health, Inc. Transaction History

Archer Investment Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$48.25 - $100.49 $183,350 - $381,862	-3,800 Reduced 93.6%	260 $18.3 Million
Q4 2021 Feb 09, 2022	SELL	$88.71 - $120.43 $44,355 - $60,215	-500 Reduced 10.96%	4,060 $406 Million
Q2 2021 Aug 05, 2021	BUY	$109.77 - $165.68 $500,551 - $755,500	4,560 New	4,560 $566 Million
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $665,054 - $937,588	-5,235 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $420,475 - $585,273	5,235 New	5,235 $585 Million
Q2 2020 Aug 13, 2020	SELL	$60.49 - $97.5 $336,324 - $542,100	-5,560 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$59.04 - $88.81 $328,262 - $493,783	5,560 New	5,560 $387,000
Q4 2019 Feb 20, 2020	SELL	$59.49 - $82.78 $243,909 - $339,398	-4,100 Closed	0 $0
Q3 2019 Apr 01, 2020	BUY	$62.59 - $110.3 $225,324 - $397,080	3,600 Added 720.0%	4,100 $262,000
Q2 2019 May 19, 2020	BUY	$63.94 - $91.11 $31,970 - $45,555	500 New	500 $43,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Archer Investment Corp with notifications on news.